Device Trial Radar · NCT06982235
Stone and Laser Therapies Post-Market Study (SALT)
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
238
Planned (sponsor's estimate)
Start
Jun 30, 2025
Primary completion
Feb 2029
Study completion Feb 2029
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- May 21, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.
Conditions
- Benign Prostate Hypertrophy(BPH)
- Renal Calculi
- Ureteral Stones, Kidney Stones
- Calculi, Urinary
- Urinary Tract Procedure
Interventions
Ureteroscope systemDevice
LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System with intrarenal pressure monitoring
Laser systemDevice
Pulse™ 120H Holmium Laser System with MOSES™ 2.0 Technology
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of Serious Adverse Events related to BSC study devicesTime frame: From procedure to 12-months after the procedure
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic Phoenix
Phoenix, Arizona
University of Miami Hospital
Miami, Florida
University of South Florida
Tampa, Florida
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.